Pre-Clinical (Discovery and Development)
Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.
Keeping tabs on pharma: Synthetic data unlocks potential in clinical trial development and dietary supplements renders coronavirus less infective
March 26 by Emily UwemedimoFind out how a dietary study uncovered a solution that could prevent the SARS-CoV-2 virus from infecting other cells
Keeping tabs on Covid-19: EMA say AstraZeneca vaccine outweighs risks and zero-emissions vehicle makes vaccines more accessible
March 19 by Emily UwemedimoFollowing concerns about AstraZeneca’s Covid-19 vaccine, the EMA continues to endorse its safety as findings reveal it does not increase the overall risk of blood clotting disorders
Keeping tabs on Covid-19: GAO addresses concerns over FDA backlog and pharma discovers crucial jigsaw piece to help fight coronavirus
March 05 by Emily UwemedimoUK diagnostics submits emergency use authorization request for T cell immune response test
Keeping tabs on Covid-19: Chinese jabs support Zimbabwe’s vaccination effort and rapid test undergoes design revamp
February 19 by Emily UwemedimoA medical diagnostics company in Germany has undergone a development stage to improve their coronavirus rapid tests – find out what happened in Pharma IQ’s latest industry round-up
Philippines FDA to speed up Covid-19 clinical trial approval decisions by 50 per cent
February 18 by Emily UwemedimoJanssen among pharma firms being provided increased transparency of regulatory decisions on clinical trial processes in the Philippines
Three biotech trends shaping pharma's digital economy
February 16 by Emily UwemedimoFind out how biotech can speed up drug development, make products cheaper to produce and provide more effective medicines for patients
Unlocking the power of data to advance pharma businesses
February 10 by Pharma IQDiscover a data-driven approach from Merck to enhance pharma’s digital business economy
Keeping tabs on Covid-19: Pharma sector not immune to pandemic’s financial pressures and stakeholders demand decisions of vaccine prices are made public
February 05 by Emily UwemedimoDiscover how the outbreak of coronavirus has caused unprecedented impacts on the pharma industry’s annual budgets
Lung cancer progress halted by Covid-19 pandemic
January 28 by Emily UwemedimoThe pandemic’s strain on health and healthcare systems leads to growing calls from healthcare experts for global government cooperation
Keeping tabs on Covid-19: UK firm tests oral delivery of Covid-19 vaccine and Novavax aims to distribute 51 million vaccines to Australia
January 22 by Emily UwemedimoThe distribution of a new Covid-19 vaccine created using nanoparticle technology has been announced to reduce Covid-19 infection rates in Australia
Keeping tabs on Covid-19: Updates on the second Covid-19 vaccine approved in the UK and Bayer’s latest global supply chain infrastructure deal
January 08 by Emily UwemedimoExplore how the pharmaceutical industry is continuing to develop Covid-19 vaccine delivery programs in 2021
Keeping tabs on Covid-19: Pharma IQ’s top four coronavirus news stories of 2020
December 23 by Emily UwemedimoRead our editor’s top picks of 2020 from Pharma IQ’s Keeping tabs on Covid-19 series